Moreover, the length of stay in the hospital showed a trend toward reduction (from 9 ± 2 days before protocol implementation, to 7 ± 5 days).
← all phrases
“showed a trend”
In the literature
The Sinupret® group also showed a trend to an antibiotic-sparing effect (2.17% in the Sinupret® group vs. 5.26% in the control group).
An initial small-scale double-blind trial with early RRMS patients showed a trend to better clinical outcomes, and a reduction in MBP-reactive T cells in myelin-treated patients, without any adverse effects ( Weiner et al., 1993a ; Hohol et al., 1996 ).
Similarly, a limited clinical trial of 13 patients using interferon alfacon-1 treatment showed a trend toward improved radiological and clinical outcomes, but without achieving statistical significance.
raffinolactis showed a trend toward a positive correlation in their abundances, it was not statistically significant.
While prevaccination eosinophil levels were not associated with survival, patients with blood eosinophilia at any point after initiation of DC-based immunotherapy showed a trend towards longer survival.
Conversely, DVB-PVP HD treatment showed a trend of post-dialysis reduction in IS and PCS greater than BHD, reaching a statistical significance only for IS ( Figure 4 B).
PYR loaded similarly between the pCD-β-MP and Dex-MP, while RIF showed a trend towards higher Dex-MP loading. 3.4.
The average, maximum, and deviation of energy consumption and medical staff from 2013 to 2016 showed a trend of increasing annually, but the increase was not significant.
The subsequent analysis of the overall survival showed a trend to a slight, but not significant improvement, in the Buparlisib-treated group versus the placebo (33.2 versus 30.4 months) [ 309 ].
The outcome results were interesting as the immune responders showed a trend toward increased survival compared to the non-immune responders.
Unexpectedly, the lower CP-690,550 dosage arm showed a trend toward the lowest rejection rate and a superior allograft function.
Unexpectedly, the lower tofacitinib dosage arm showed a trend toward the lowest rejection rate and a superior allograft function.
Most cultivars showed a trend of increasing activity during maturation; however, the HHT activity peaked at different times and had high variation at final harvest among cultivars (Peterson and Dimberg, 2008 ).
Interestingly, though being previously described as miR-130a target gene, PPARγ exhibited no significant regulation by miR-130a in our luciferase reporter assay experiments (p = 0.07; Student’s t-test), but showed a trend towards regulation.
Our results showed a trend of elevated systemic hs-CRP among subjects with (L)ALR.
Data from a phase II study evaluating MDT for oligorecurrent PC showed a trend toward improved ADT‐free survival at 3 years’ follow‐up (median ADT‐free survival) was 13 months (80% CI, 12‐17 months) for the surveillance group and 21 months (80% CI, 14‐29 months) for the MDT group (HR, 0.60 [80% CI, 0.40‐0.90]; P = .11).
Results showed a trend similar to other studies on histamine production against the storage time (Kung, Huang, Lin, Liaw, Lee and Tsai, 2015; Zou and Hou, 2016).
Compared with each other, although not significant, A‐PRF + showed a trend for higher proliferation than L‐PRF and FGF (increased proliferation 19.6% and 42.5%, respectively).
The changes of Cyt-Aco activity showed a trend of “up-down-stable”.
A 24-hour MSTN treatment showed a trend in slow cell-cycle progression (control, 45 ± 3%; MSTN, 48.5 ± 1.8%; p = NS; Supplementary Fig.
Gfat1 TG mice also showed a trend of thicker LV internal diameter (LVID) in systole as compared with those in the control group (Supplementary Fig. 9c ).
tau showed a trend favoring females in the ratio of female/male offspring, producing an excess of females which would allow the reproduction rate to increase in order to maintain or increase the size of the population.
The Kyn / Trp ratio showed a trend to increase and 5‐HTP / Trp ratio increased significantly in AT‐2 engrafted rats compared to control (Figure 2 D,E). 3.2 Tryptophan, kynurenine, and serotonin levels in tissues We next quantified levels of Trp, Kyn, and serotonin in several tissues, including liver, small intestine (jejunum and ileum), immune tissues (spleen and thymus), and tumor.
Survival analysis showed a trend toward a longer median progression‐free survival for patients with high SRD5A1 expression levels and high AR pathway activity scores.